Try our beta test site

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00962611
First received: August 19, 2009
Last updated: November 9, 2016
Last verified: November 2016